Gastroduodenal lesions detected during small bowel capsule endoscopy: incidence, diagnostic and therapeutic impact

Fernández, José María Díaz; Sáinz, Ignacio Fernández Urién; Ollo, Beatriz Zabalza; Dueñas, Cristina Saldaña; Guimera, M Montañés; Elosua, Alfonso; Vila, Juan J.

doi:10.17235/reed.2017.5114/2017

Cited by 9 publications

(16 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Juanmartiñena Fernández et al[31] retrospectively analyzed data from 2217 consecutive SBCE performed in a tertiary centre in Spain between 2008 and 2016. 52.3% of the patients were referred for occult GI bleeding.…”

Section: Non-small Bowel Lesions Detected By Small Bowel Capsule Endomentioning

confidence: 99%

“…52.3% of the patients were referred for occult GI bleeding. The rest were referred for Crohn’s disease, abdominal pain, chronic diarrhoea or other indications[31]. SBCE detected gastroduodenal lesions in 566 patients.…”

Section: Non-small Bowel Lesions Detected By Small Bowel Capsule Endomentioning

confidence: 99%

“…Among patients with gastric or duodenal lesions detected at SBCE, 75.4% and 86.4% respectively did not have these abnormalities found at prior endoscopies. Lesions identified more frequently in the stomach included erosions, vascular lesions and findings suggestive of chronic gastritis, while lesions found more frequently in the duodenum included erosions, erythema or vascular lesions[31]. Lesions revealed by SBCE led to a change to the initial therapeutic strategy in 60.6% of the patients.…”

Section: Non-small Bowel Lesions Detected By Small Bowel Capsule Endomentioning

confidence: 99%

“…Lesions revealed by SBCE led to a change to the initial therapeutic strategy in 60.6% of the patients. In 12.8% an endoscopic intervention was carried out (most frequently argon plasma coagulation for vascular changes) and in 1.2% a surgical intervention was performed[31]. Juanmartiñena Fernández et al[32] also analyzed 526 consecutive SBCE performed in their centre between 2008 and 2011, in order to assess detection of colonic lesions identified at SBCE[32].…”

Section: Non-small Bowel Lesions Detected By Small Bowel Capsule Endomentioning

confidence: 99%

See 3 more Smart Citations

Non-small bowel lesion detection at small bowel capsule endoscopy: A comprehensive literature review

Koffas¹,

Laskaratos

Epstein

2018

WJCC

View full text Add to dashboard Cite

Small bowel capsule endoscopy is a minimally-invasive endoscopic investigation that is often used in clinical practice to investigate overt or occult gastrointestinal (GI) bleeding among other clinical indications. International guidance recommends small bowel capsule endoscopy as a first-line investigation to detect abnormalities in the small bowel, when gastroscopy and colonoscopy fail to identify a cause of GI bleeding. It can diagnose with accuracy abnormalities in the small bowel. However, there has been increasing evidence indicating that small bowel capsule endoscopy may also detect lesions outside the small intestine that are within the reach of conventional endoscopy and have been probably missed during prior endoscopic investigations. Such lesions vary from vascular deformities to malignancy and their detection often alters patient management, leading to further endoscopic and/or surgical interventions. The current study attempts to review all available studies in the literature and summarise their relevant findings.

show abstract

Section: Non-small Bowel Lesions Detected By Small Bowel Capsule Endomentioning

confidence: 99%

Section: Non-small Bowel Lesions Detected By Small Bowel Capsule Endomentioning

confidence: 99%

Section: Non-small Bowel Lesions Detected By Small Bowel Capsule Endomentioning

confidence: 99%

Section: Non-small Bowel Lesions Detected By Small Bowel Capsule Endomentioning

confidence: 99%

See 2 more Smart Citations

Non-small bowel lesion detection at small bowel capsule endoscopy: A comprehensive literature review

Koffas¹,

Laskaratos

Epstein

2018

WJCC

View full text Add to dashboard Cite

show abstract

“…This is different from the results in adults, in whom obscure gastrointestinal bleeding is the main indication for VCE. [ 18 , 19 ] Recently, a systemic review reported that the pooled diagnostic yield of VCE for chronic abdominal pain was 20.9%; [ 20 ] Huang et al showed a 28.15% positive rate of VCE findings in the small bowel in chronic abdominal pain patients. [ 6 ] In this study, abdominal pain was the main indicator for VCE (54.1%), with 49.1% diagnostic yield in patients with chronic abdominal pain.…”

Section: Discussionmentioning

confidence: 99%

Clinical features of capsule endoscopy in 825 children

Huang

Wang

et al. 2020

Medicine

View full text Add to dashboard Cite

Video capsule endoscopy (VCE) can detect mucosal lesions in the intestine, especially in the small bowel. Our study aims to evaluate the applications of VCE for pediatric gastrointestinal diseases. In this retrospective study, we included all patients who underwent VCE between December 2012 and December 2018. Clinical information and VCE data were analyzed. Among 828 patients, the completion rate was 99.6% (n = 825), with an average age of 10.2 ± 3.3 years old. A total of 459 VCE procedures showed abnormalities, and the overall diagnostic yield was 55.6%. The most common indications for VCE were abdominal pain among 505 (61.2%) patients and hematochezia (10.1%) among 83. Among the positive results of VCE, small bowel ulcers accounted for the highest percentage (57.7%), of which 164 cases were diagnosed as inflammatory bowel disease. For obscure gastrointestinal bleeding, 12 cases were diagnosed as Meckel's diverticulum. In terms of the small bowel transit time of VCE, compared with the negative group [288 (216.5, 390.3) min] and the enteritis group [277 (192.5, 374.8) min], a longer transit time was needed in the small bowel ulcer group [332.5 (240, 451.5) min, P < .01]. There were no correlations of positive VCE findings with anemia, the white blood cell count, the C-reactive protein level or the small bowel transit time according to Spearman rank analysis. VCE is relatively well tolerated and safe in children and has great value for the diagnosis and treatment of abdominal pain, especially inflammatory bowel disease and obscure gastrointestinal bleeding.

show abstract

Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022

et al. 2022

View full text Add to dashboard Cite

Main Recommendations MR1 ESGE recommends small-bowel capsule endoscopy as the first-line examination, before consideration of other endoscopic and radiological diagnostic tests for suspected small-bowel bleeding, given the excellent safety profile of capsule endoscopy, its patient tolerability, and its potential to visualize the entire small-bowel mucosa.Strong recommendation, moderate quality evidence. MR2 ESGE recommends small-bowel capsule endoscopy in patients with overt suspected small-bowel bleeding as soon as possible after the bleeding episode, ideally within 48 hours, to maximize the diagnostic and subsequent therapeutic yield.Strong recommendation, high quality evidence. MR3 ESGE does not recommend routine second-look endoscopy prior to small-bowel capsule endoscopy in patients with suspected small-bowel bleeding or iron-deficiency anemia.Strong recommendation, low quality evidence. MR4 ESGE recommends conservative management in those patients with suspected small-bowel bleeding and high quality negative small-bowel capsule endoscopy.Strong recommendation, moderate quality evidence. MR5 ESGE recommends device-assisted enteroscopy to confirm and possibly treat lesions identified by small-bowel capsule endoscopy.Strong recommendation, high quality evidence. MR6 ESGE recommends the performance of small-bowel capsule endoscopy as a first-line examination in patients with iron-deficiency anemia when small bowel evaluation is indicated.Strong recommendation, high quality evidence. MR7 ESGE recommends small-bowel capsule endoscopy in patients with suspected Crohn’s disease and negative ileocolonoscopy findings as the initial diagnostic modality for investigating the small bowel, in the absence of obstructive symptoms or known bowel stenosis.Strong recommendation, high quality evidence. MR8 ESGE recommends, in patients with unremarkable or nondiagnostic findings from dedicated small-bowel cross-sectional imaging, small-bowel capsule endoscopy as a subsequent investigation if deemed likely to influence patient management.Strong recommendation, low quality evidence. MR9 ESGE recommends, in patients with established Crohn’s disease, the use of a patency capsule before small-bowel capsule endoscopy to decrease the capsule retention rate.Strong recommendation, moderate quality evidence. MR10 ESGE recommends device-assisted enteroscopy (DAE) as an alternative to surgery for foreign bodies retained in the small bowel requiring retrieval in patients without acute intestinal obstruction.Strong recommendation, moderate quality evidence. MR11 ESGE recommends DAE-endoscopic retrograde cholangiopancreatography (DAE-ERCP) as a first-line endoscopic approach to treat pancreaticobiliary diseases in patients with surgically altered anatomy (except for Billroth II patients).Strong recommendation, moderate quality evidence.

show abstract

Gastroduodenal lesions detected during small bowel capsule endoscopy: incidence, diagnostic and therapeutic impact

Cited by 9 publications

References 29 publications

Non-small bowel lesion detection at small bowel capsule endoscopy: A comprehensive literature review

Non-small bowel lesion detection at small bowel capsule endoscopy: A comprehensive literature review

Clinical features of capsule endoscopy in 825 children

Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022

Contact Info

Product

Resources

About